Neonatal Lung Ultrasound in RDS: LUS Score and Surfactant Threshold
What is the Neonatal LUS Score
Lung ultrasound (LUS) is a bedside, radiation-free method applicable in neonatal intensive care for assessing lung aeration. The semi-quantitative score proposed by Brat et al. (2015) and further developed by the De Luca/Raimondi group has become the most widely used neonatal scale. Each lung is divided into three zones — upper anterior, lower anterior, and lateral; a total of six regions are assessed (right and left upper anterior, lower anterior, and lateral).
Grading of Each Zone (0–3 Points)
| Score | Ultrasound Appearance | Aeration |
|---|---|---|
| 0 | A-lines only (horizontal repeats of the pleural line) | Normal |
| 1 | ≥3 separate (discrete) B-lines | Moderately reduced |
| 2 | Confluent B-lines ("white lung"), ± subpleural consolidations | Significantly reduced |
| 3 | Extensive consolidation with air bronchograms | Severely reduced |
Scores from six zones are summed to yield a total LUS score of 0–18: higher scores indicate worse aeration. Extended versions of the scale exist (10 or 12 zones, including posterior fields), but the 6-zone anterior-lateral scheme is the primary validated approach for surfactant decisions.
Threshold for Surfactant Administration
There is no single universal threshold value: the specific threshold depends on the scale version, gestational age, and reference standard (systematic review by Capasso/Raimondi, 2023). Key findings:
| Study | Population | Threshold / Indicator | Accuracy |
|---|---|---|---|
| Brat, 2015 (JAMA Pediatr) | <34 weeks on CPAP | LUS ≥4 | Sensitivity 100%, specificity 61%; AUC 0.93 |
| De Martino, 2018 (Pediatrics) | ≤30 weeks on CPAP | first dose | AUC 0.94; accuracy 89% (repeat dose AUC 0.80) |
| Aldecoa-Bilbao, 2020 (Pediatr Pulmonol) | <32 weeks | SpO₂/FiO₂ model + LUS | AUC 0.95–0.97 |
| Capasso/Raimondi, 2023 (meta-analysis, 697 infants) | preterm | various thresholds | Pooled sensitivity 89%, specificity 86%; AUC 0.88 |
In summary (meta-analysis of 7 studies, 697 infants): LUS score predicts the need for first-dose surfactant with sensitivity 89% and specificity 86% (AUC 0.88), despite variation in thresholds across studies.
What Guidelines Recommend
The European Consensus Guidelines on the Management of RDS (Sweet et al., 2022) note that "lung ultrasound, when properly performed, can serve as a method for earlier diagnosis of RDS, apparently without increasing the overall number of treated infants." In the proposed protocol, surfactant is administered to a deteriorating infant with RDS "when FiO₂ > 0.30 on CPAP with pressure ≥6 cm H₂O or if lung ultrasound indicates the need for surfactant" (evidence level B2).
Clinical Benefit of LUS-Guided Strategy
In a randomized controlled trial (Zhang et al., 2025; preterm infants <32 weeks), a strategy combining RDS diagnosis by ultrasound and surfactant administration by LUS criteria reduced the frequency and duration of invasive mechanical ventilation, allowed earlier administration of the first dose, and reduced total surfactant volume. It also decreased radiation exposure during the first week of life. Predictive models combining LUS with the SpO₂/FiO₂ ratio (Aldecoa-Bilbao, 2020) achieve AUC 0.95–0.97 and enable anticipatory surfactant administration—within 2 hours of life.
Limitations
- Operator-dependence and learning curve; standardization of scanning zones and device settings is necessary.
- Threshold values do not transfer directly between scale versions and devices (threshold variability—Capasso/Raimondi, 2023).
- LUS complements but does not replace clinical assessment and FiO₂ monitoring; the final decision on surfactant remains multifactorial.
Frequently asked questions
What LUS score threshold indicates the need for surfactant?
There is no single universal threshold. In the original Brat scale (infants <34 weeks on CPAP), a threshold of ≥4 demonstrated 100% sensitivity with 61% specificity. The specific threshold depends on the scale version, gestational age, and clinical context.
How is the neonatal LUS score structured?
Each lung is divided into 3 zones (upper anterior, lower anterior, lateral)—totaling 6 regions; each is scored 0–3 points (0 = A-lines, 3 = extensive consolidation). The sum of all zones yields a total score of 0–18.
How accurate is LUS for predicting surfactant need?
According to a meta-analysis of 7 studies (697 infants)—sensitivity 89%, specificity 86% (AUC 0.88); in extremely preterm infants AUC reaches 0.94 (De Martino, 2018).
What does the European Consensus on RDS (2022) recommend?
Administer surfactant to a deteriorating infant with RDS when FiO₂ > 0.30 on CPAP with pressure ≥6 cm H₂O or if lung ultrasound indicates the need for surfactant (evidence level B2).
Does LUS replace clinical assessment and FiO₂ monitoring?
No. LUS complements clinical evaluation and oxygen monitoring; the final decision on surfactant administration remains multifactorial.